Core Viewpoint - The trademark dispute between Wanglaoji and JDB (Jiangsu Da Bao) has escalated, reflecting the broader trend of Chinese brands seeking to expand internationally amidst a saturated domestic market [1][2][3] Trademark Dispute - The trademark battle reignited on September 30, 2025, with JDB claiming a significant victory in protecting its overseas "Wanglaoji" trademark rights [2] - Wanglaoji responded by asserting that JDB's claims were factually incorrect and emphasized its ownership of the "Wanglaoji" brand, registered in over 100 countries [2][3] - The core of the dispute lies in the territorial nature of trademark rights, with both companies engaged in legal battles over the ownership and validity of their respective trademarks [3][7] Market Expansion Strategies - Both companies are pursuing international market expansion, with JDB sponsoring cultural events and Wanglaoji launching products in Germany [4][5] - The competition for international trademark rights is seen as crucial for both brands' future growth and market positioning [4][5] Industry Context - The domestic herbal tea market is experiencing stagnation, with both companies facing competition from new beverage categories [8][9] - Wanglaoji reported a revenue of 64.99 billion yuan in 2025, a year-on-year increase of 8.38%, but this follows a significant decline in 2024 [8] - The overall herbal tea market in China has entered a period of stagnation, with a 10-year growth rate of approximately 20% since 2014 [8][9] Long-term Implications - The prolonged legal disputes have drained resources from both companies, hindering their ability to innovate and adapt to market changes [9][10] - Industry experts suggest that if both companies can reach a compromise, such as sharing trademark rights or dividing market territories, it could lead to mutual benefits and enhanced market presence [10]

Group 1 - Wanglaoji and JDB have resumed their public feud, trending on social media with topics like "Wanglaoji has a problem, go to the hospital" and "Wanglaoji is the first to get angry" [1] - The conflict has escalated with both companies making statements regarding trademark disputes, particularly concerning the overseas rights to the Wanglaoji brand [4][10] - JDB claims to have successfully defended its overseas trademark rights in multiple lawsuits, marking a significant step in its international branding strategy [4][8] Group 2 - Wanglaoji's parent company, Baiyunshan, asserts that it holds the legal rights to the Wanglaoji trademark globally, having registered it in over 100 countries [10][11] - Both companies have been engaged in a long-standing trademark dispute, with JDB emphasizing its acquisition of the Wanglaoji brand's overseas rights in the early 2000s [10][14] - The ongoing rivalry has implications for both companies' market performance, with potential impacts on their respective sales and brand positioning [14][16] Group 3 - The herbal tea market remains a viable business opportunity, with significant growth potential in overseas markets despite a slowdown in domestic growth [14][15] - Wanglaoji reported a revenue of 6.499 billion yuan in the first half of 2025, a year-on-year increase of 8.38%, and a net profit of 1.295 billion yuan, up 15.87% [14] - JDB has also been expanding its market presence, with a reported 28.31% market share in the domestic plant beverage category, closely following Wanglaoji's 46.33% [16]

Core Viewpoint - The ongoing trademark dispute between Wanglaoji and Jia Duo Bao highlights the complexities of intellectual property rights as Chinese brands expand internationally, with both companies asserting their claims over the "Wanglaoji" trademark in various global markets [1][3][6]. Group 1: Trademark Dispute Developments - On September 30, Jia Duo Bao announced victories in multiple lawsuits in Canada and the EU, claiming to protect its overseas trademark rights for "Wanglaoji," asserting ownership since the early 2000s and registration in over 60 countries [1]. - Wanglaoji quickly countered, accusing Jia Duo Bao of misleading the public and revealing that it has initiated trademark protection actions in 21 countries, with some jurisdictions already ruling in favor of Wanglaoji [2]. - The trademark conflict stems from over two decades of partnership and subsequent legal battles, with a recent ruling ordering Jia Duo Bao to pay Wanglaoji 317 million yuan for trademark infringement [3]. Group 2: Market Context and Growth Challenges - Despite dominating the domestic herbal tea market, both companies face stagnation as new beverage categories divert consumer interest, prompting a focus on international expansion [4]. - Wanglaoji has seen its overseas market grow 6.5 times over the past decade, with a compound annual growth rate exceeding 25%, and has registered its trademarks in over 100 countries [4]. - Both companies are establishing local production bases to enhance their market presence, with Wanglaoji partnering with local firms to build an 800 million can annual capacity in Malaysia [4]. Group 3: Intellectual Property Challenges - The trademark battle reflects broader challenges faced by Chinese companies in protecting their intellectual property abroad, with over 2,000 instances of trademark registration disputes reported since the 1980s, leading to significant asset losses [6][7]. - The regional nature of trademark laws complicates enforcement, as different jurisdictions have varying principles regarding trademark rights, impacting both companies' strategies [6][7]. - The difficulty in proving malicious registration adds to the complexity, as companies must gather evidence across borders, which can be costly and time-consuming [7]. Group 4: Strategic Recommendations - Experts suggest that traditional brands must integrate intellectual property into their core strategies, emphasizing the importance of comprehensive planning and proactive trademark registration [2][8]. - Companies are advised to enhance their brand narratives and cultural heritage to secure broader trademark protections and avoid potential conflicts in international markets [8]. - The case serves as a cautionary tale for Chinese enterprises aiming for global expansion, underscoring the necessity of clarifying trademark rights before entering new markets [9].

Core Viewpoint - The trademark dispute between Wanglaoji and JDB has extended to the global market, with both companies claiming ownership of the "Wanglaoji" trademark overseas, leading to escalating tensions and legal actions [1][4]. Group 1: Trademark Ownership Claims - JDB claims to have registered the "Wanglaoji" trademark in over 60 countries and regions worldwide, emphasizing its legal victories in Canada and the EU [2][4]. - Wanglaoji asserts that the trademark belongs to Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd., with a clear historical lineage and legal documentation supporting their claim [4][10]. - As of September 30, Wanglaoji has completed trademark registrations in over 100 countries and regions, while JDB's claims are characterized as "malicious registration" by Wanglaoji [4][10]. Group 2: Legal Actions and Responses - The dispute intensified after JDB announced its overseas trademark victories on September 30, prompting Wanglaoji to issue a statement accusing JDB of misleading the public [2][4]. - Following a series of legal battles in China, a court ruled in 2023 that JDB infringed on Wanglaoji's trademark rights, ordering JDB to pay 317 million yuan in damages [10]. - The ongoing trademark battle is seen as a strategic move by both companies to secure their positions in the shrinking domestic market while expanding internationally [10]. Group 3: Market Strategies - JDB has established a production base overseas since 2016, achieving approximately 10% of its sales from international markets [10]. - Wanglaoji is actively working to make international sales a significant part of its revenue, aiming for a single market to contribute around 1 billion yuan [12]. - Both companies have adopted different strategies for their foreign trademarks, with JDB using names that resonate with overseas Chinese consumers, while Wanglaoji has introduced the "WALOVI" brand to establish an independent international identity [10][11].

Core Viewpoint - The trademark dispute between Jia Duo Bao and Wang Lao Ji has intensified, particularly focusing on overseas trademark rights, as both companies seek to expand in international markets amid slowing domestic growth in the herbal tea sector [1][3][4]. Trademark Dispute Background - The conflict stems from a historical agreement where Li Yimin, former general manager of Guangzhou Pharmaceutical Group, facilitated the transfer of the "Wang Lao Ji" trademark to Jia Duo Bao's parent company, Hongdao Group, in exchange for bribes totaling HKD 3 million [1][11][15]. - Following the exposure of Li Yimin's bribery case, Guangzhou Pharmaceutical Group reassessed the licensing agreements, claiming the trademark was undervalued, with usage fees at only 0.03% of sales compared to the industry norm of 5%-30% [1][16][17]. Recent Developments - On September 29, Jia Duo Bao announced victories in multiple lawsuits in Canada and the EU, asserting its rights to the "Wang Lao Ji" trademark in over 60 countries through its subsidiary, Multi Access Limited [4][20]. - Conversely, Wang Lao Ji's parent company, Baiyunshan, issued a statement disputing Jia Duo Bao's claims, asserting that the trademark ownership is clear and legally documented [5][4]. Market Context - The herbal tea industry in China is experiencing a slowdown, with market growth rates declining significantly from 16.7% in 2012 to a mere 6.8% projected over the next five years [20][19]. - In contrast, the global plant beverage market is booming, with a compound annual growth rate of nearly 10% from 2019 to 2024, particularly in emerging markets like Southeast Asia [22][26]. Financial Performance - Baiyunshan reported a 12.7% decline in revenue from its health segment, which primarily includes Wang Lao Ji, with total revenue around CNY 9.7 billion for 2024 [21]. - In the first half of 2025, Wang Lao Ji's health segment showed signs of recovery, with a revenue increase of 8.38% to CNY 6.5 billion, and a net profit rise of 15.87% [24]. Strategic Moves - Wang Lao Ji is actively pursuing international expansion, launching the new overseas brand "WALOVI" and registering it in over 100 countries [5][22]. - The ongoing trademark battle is crucial for Jia Duo Bao, as securing overseas rights could enhance its market position and attract potential investors amid plans for a Hong Kong IPO [26].

Core Viewpoint - The ongoing trademark dispute between Wanglaoji and JDB (Jiangsu Dahe Beverage) has escalated, focusing on overseas trademark rights, with both companies asserting their claims in various international markets [2][4]. Group 1: Trademark Dispute Background - The trademark conflict between Wanglaoji and JDB has been ongoing for over a decade, involving issues of trademark licensing, commercial packaging, and advertising slogans [2][3]. - Wanglaoji's brand has a history dating back to the Qing Dynasty, and it became a national beverage during its operation under JDB [3]. - The initial trademark licensing agreement between Guangzhou Pharmaceutical Group and JDB was signed in the 1990s, with subsequent contracts leading to disputes over their validity due to alleged bribery [3][4]. Group 2: Recent Developments - JDB claims to have successfully defended its overseas trademark rights in multiple lawsuits, asserting ownership of the Wanglaoji brand in over 60 countries [2][5]. - Wanglaoji has countered these claims, accusing JDB of malicious trademark registration and has initiated legal actions in 21 countries, with some rulings already in its favor [6][5]. - The legal status of JDB's overseas trademark registrations varies by country, with some jurisdictions recognizing its legitimacy while others do not [6]. Group 3: Market Expansion Strategies - Both companies are aggressively pursuing international market expansion, with Wanglaoji launching a new brand name "WALOVI" to cater to global consumers [7][8]. - Wanglaoji's overseas market has seen a 6.5-fold growth over the past decade, with a compound annual growth rate exceeding 25% [7]. - JDB's international strategy appears more subdued, yet it continues to expand its marketing channels and product reach globally [8]. Group 4: Industry Trends - The global plant-based beverage market is experiencing significant growth, with a compound annual growth rate of nearly 10% from 2019 to 2024 [7]. - The competition in the herbal tea segment is intensifying, with both companies needing to adapt to changing consumer preferences and market dynamics [9]. - Analysts suggest that the trademark dispute is a reflection of the broader challenges faced by Chinese companies in international markets, emphasizing the importance of trademark rights in global expansion efforts [9].

Core Viewpoint - The ongoing trademark dispute between Wanglaoji and JDB (Jiangsu Dahe Beverage) has intensified, focusing on the overseas trademark ownership of "Wanglaoji" [3][22]. Group 1: Trademark Dispute Developments - JDB recently claimed ownership of the overseas trademark rights for "Wanglaoji," citing victories in multiple legal cases in Canada and the EU [6][9]. - Wanglaoji responded sharply, asserting that the trademark rights belong to Guangzhou Pharmaceutical Group and accusing JDB of maliciously registering trademarks to hinder their international expansion [15][19]. - The dispute has historical roots dating back to 2011, with both companies engaging in a protracted legal battle over trademark rights [33][34]. Group 2: Legal Victories and Strategies - JDB's Multi Access Limited successfully defended its trademark rights in Canadian and EU courts, marking significant progress in its international branding strategy [7][9]. - JDB has established trademark rights in over 60 countries and regions, positioning itself as the legitimate rights holder for the "Wanglaoji" brand globally [11][14]. - Wanglaoji has also been proactive in its international strategy, launching the English brand "WALOVI" and expanding its product offerings to international markets [28][30]. Group 3: Market Position and Financial Performance - Wanglaoji reported a revenue of 6.499 billion yuan in the first half of 2025, reflecting an 8.38% year-on-year growth, with profits also increasing significantly [27]. - The plant-based beverage market is experiencing rapid growth, with a compound annual growth rate of nearly 10% from 2019 to 2024, indicating a favorable environment for both brands [31]. - As of June 2025, Wanglaoji holds a 46.33% market share in the plant beverage category in China, while JDB follows with 28.31% [31].

文|《BUG》栏目 闫妍 王老吉和加多宝的纷争又双叒叕开启了。 近日，王老吉与加多宝这对商界"老对手"再度隔空交锋，围绕"王老吉"境外商标归属问题展开新一轮舆 论攻防。自9月底至10月初，双方通过官方渠道密集发布声明，就海外商标权益范围各执一词、互不相 让。 加多宝集团近日突然发布声明，声称拥有王老吉海外商标所有权。当晚，王老吉回击，其严正声明只有 12字，"有病去医院，有事找法院。谢谢！" 王老吉和加多宝这场旷日持久的商标纠纷，其根源可追溯至2011年，至今已过去了14年。针对此次商标 纠纷的最新进展，《BUG》栏目尝试联系双方，双方均未正面回应此事。 "王老吉"境外商标归谁？ 这次的"口水战"要追溯到9月30日，加多宝发布了一份颇具"胜利意味"的声明，宣告加多宝加拿大凉茶 维权告捷。 加多宝在这份声明中表示，"近日，加多宝集团在全球知识产权维权领域接连取得重大胜利。其关联公 司万捷有限公司（Multi Access Limited）在加拿大联邦法院及欧盟普通法院的多起诉讼中，均成功捍 卫'王老吉'海外系列商标的合法权益，标志着加多宝品牌国际化战略迈上新台阶。" 看到加多宝这份"胜利宣言"，王老吉方面立即展 ...

Core Viewpoint - The ongoing trademark dispute between Wanglaoji and JDB has escalated, with both companies making conflicting claims regarding the ownership of the "Wanglaoji" trademark in overseas markets [1][2][4]. Group 1: Background of the Dispute - The trademark conflict began in 2010 and has persisted for over a decade, with both companies now focusing on expanding their presence in international markets as domestic growth slows [5]. - JDB claims to have legally obtained the overseas rights to the "Wanglaoji" trademark in the early 2000s, while Wanglaoji asserts that JDB maliciously registered the trademark to hinder its international expansion [2][4]. Group 2: Legal Actions and Responses - Wanglaoji has registered the "Wanglaoji" and "WALOVI" trademarks in over 100 countries and regions, with clear ownership rights as of September 30, 2025 [3]. - Wanglaoji has initiated legal actions in 21 countries and regions, including Macau and Brazil, against JDB for trademark misuse, with 10 jurisdictions already supporting Wanglaoji's claims [3]. - JDB's response emphasizes its strategic intent to expand into over 60 countries and regions, claiming that its trademark registrations are aimed at market development [4]. Group 3: Market Strategies - Wanglaoji has launched international products under the "WALOVI" brand and plans to localize production in Malaysia, targeting the U.S. and Southeast Asia as key markets [5]. - JDB is also pursuing overseas expansion, focusing on markets in Southeast Asia and Hong Kong, with plans for a potential listing in Hong Kong [5]. Group 4: Legal Environment - Legal experts note that the trademark dispute is complicated by differing trademark governance systems across countries, leading to varying interpretations of trademark rights [6]. - The ongoing global market strategies of both companies suggest that the trademark conflict will continue to unfold through legal channels in various jurisdictions [6].

Core Viewpoint - The ongoing trademark dispute between Jia Duo Bao and Wang Lao Ji has intensified, with both companies making significant claims regarding their rights to the "Wang Lao Ji" brand in international markets [4][6][14]. Group 1: Trademark Ownership Claims - Jia Duo Bao asserts that it acquired the overseas trademark rights for "Wang Lao Ji" in the early 2000s and has since registered the trademark in over 60 countries [4][9]. - Wang Lao Ji claims that the current trademark owner is Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd., and that it has registered the "Wang Lao Ji" and "WALOVI" trademarks in over 100 countries [13][14]. Group 2: Recent Developments - In August 2023, Wang Lao Ji launched its international core brand "WALOVI" and introduced four international canned products [6]. - Jia Duo Bao reported victories in multiple lawsuits in Canada and the EU, defending its overseas trademark rights [9]. Group 3: Historical Context - The trademark dispute dates back to 2012 when an arbitration ruling invalidated the trademark licensing agreements between Guangzhou Pharmaceutical Group and Jia Duo Bao's parent company [14]. - In 2023, a court ruled that Jia Duo Bao must pay 317 million yuan for trademark infringement, which Jia Duo Bao plans to appeal [14].